228 related articles for article (PubMed ID: 26021968)
1. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
[TBL] [Abstract][Full Text] [Related]
2. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
4. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Neural Transm (Vienna); 2015 Jan; 122(1):59-68. PubMed ID: 25448875
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.
Shi Y; Yuan Y; Xu Z; Pu M; Wang C; Zhang Y; Liu Z; Wang C; Li L; Zhang Z
J Affect Disord; 2012 Feb; 136(3):558-66. PubMed ID: 22119081
[TBL] [Abstract][Full Text] [Related]
6. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
7. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
9. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Yeh YW; Chen CJ; Jang FL; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Shyu JF; Wan FJ; Lu RB; Huang SY
J Psychiatr Res; 2015 Feb; 61():33-9. PubMed ID: 25512257
[TBL] [Abstract][Full Text] [Related]
10. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
[TBL] [Abstract][Full Text] [Related]
11. [Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response].
Sun XY; Zhang ZJ; Shi YY; Xu Z; Pu MJ; Geng LY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):26-30. PubMed ID: 23450474
[TBL] [Abstract][Full Text] [Related]
12. Kinase gene haplotypes and gene-gene interactions in the Ras-Raf-MAPK signaling pathway: association with antidepressant remission.
Wang CJ; Zhang ZJ; Xu Z; Shi YY; Pu MJ; Zheng Z; Wang XZ; Zhang YM; Li LJ
Int Clin Psychopharmacol; 2013 Sep; 28(5):245-54. PubMed ID: 23727904
[TBL] [Abstract][Full Text] [Related]
13. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
[TBL] [Abstract][Full Text] [Related]
14. [Influence of interleukin-1 beta gene polymorphism and childhood maltreatment on antidepressant treatment].
Chen Y; Zhang Z; Xu Z; Pu M; Geng L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):801-4. PubMed ID: 26663052
[TBL] [Abstract][Full Text] [Related]
15. Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response.
Yuan B; Sun X; Xu Z; Pu M; Yuan Y; Zhang Z
BMC Psychiatry; 2020 Aug; 20(1):408. PubMed ID: 32795354
[TBL] [Abstract][Full Text] [Related]
16. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
[TBL] [Abstract][Full Text] [Related]
17. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
[TBL] [Abstract][Full Text] [Related]
18. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
19. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance.
Mandelli L; Mazza M; Martinotti G; Tavian D; Colombo E; Missaglia S; Di Nicola M; De Ronchi D; Negri G; Colombo R; Janiri L; Serretti A
J Psychopharmacol; 2010 Dec; 24(12):1747-54. PubMed ID: 20142305
[TBL] [Abstract][Full Text] [Related]
20. CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
Zhu Y; Zhang N; Ren D; Bi Y; Xu F; Niu W; Sun Q; Guo Z; Yuan R; Yuan F; Wu X; Cao Y; Yang F; Wang L; Du L; Li W; Xu Y; Li X; Zhu L; He L; Shi L; He G; Yu T
Clin Neuropharmacol; 2019; 42(2):32-36. PubMed ID: 30875344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
